Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,951.00
Bid: 2,951.00
Ask: 2,952.00
Change: 1.00 (0.03%)
Spread: 1.00 (0.034%)
Open: 2,947.00
High: 2,966.00
Low: 2,934.00
Prev. Close: 2,950.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3i Group plc procuring sale of B Shares

14 May 2014 07:01

RNS Number : 0351H
3i Group PLC
14 May 2014
 



3i Group plc

14 May 2014

3i Group plc

3i Group plc procuring sale of B Shares

 

3i Group plc (the "Company") is sending a letter to all holders of B Shares (the "B Shareholders") informing them that the Company has made arrangements with Merrill Lynch International ("MLI") for MLI to offer to purchase all the issued B Shares for cash at a price of 131.4364 pence per B Share. There are currently 4,635,018 B Shares in issue.

The offer from MLI to purchase B Shares (the "Offer") will be accepted on behalf of the B Shareholders by 3i Investments plc, which has been appointed by the Company to act on behalf of the B Shareholders pursuant to Article 140(E) of the Company's Articles of Association.

It is expected that the Offer will be accepted and settled on 13 June 2014 on behalf of the B Shareholders on the register of members at the close of business on 12 June 2014 and that the consideration due to the B Shareholders under the Offer (rounded down for each holding to the nearest whole number of pence) will be posted to them, on behalf of MLI, by the Company's Registrars, Equiniti Limited, on or around 20 June 2014. To facilitate this compulsory acquisition, the B Share ISIN (GB00B16PRC61) will be disabled for settlement within CREST from 4.30 pm on 12 June 2014. The B Shareholders who hold their B Shares in CREST will receive their cash proceeds through CREST on or around 20 June 2014.

The price of 131.4364 pence per B Share to be paid under the Offer has been calculated as 127 pence per B Share plus an amount equal to the accrued but unpaid dividend up to and including 19 June 2014, and is equal to the amount per B Share to which the B Shareholders would be entitled were the Company to be wound up on 20 June 2014 as prescribed by Article 140(E) of the Company's Articles of Association.

No action is required from the B Shareholders in order to receive the proceeds from the Offer, nor indeed is there any option for them to retain their B Shares or to select any other consideration. When the Offer has been accepted in respect of all the B Shares and MLI holds those shares, MLI will have the right to require the Company to purchase from MLI all the B Shares. If the B Shares are sold by MLI to the Company those shares will be cancelled (and subsequently delisted) and not held as treasury shares.

For further information, contact:

Kathryn van der Kroft, Communications Director

Tel: +44 20 7975 3021

Silvia Santoro, Investor Relations Director

Tel: +44 20 7975 3258

 

Notes to editors:

1. 3i is a leading international investor focused on mid-market private equity, infrastructure and debt management across Europe, Asia and the Americas. For further information please refer to www.3i.com.

2. The Company issued B Shares in 2006 and 2007 as part of arrangements to return value to shareholders. A number of offers to purchase these B Shares were made in 2006 to 2009 which gave shareholders flexibility as to when they received the proceeds of the return of value and, in certain cases, as to whether the proceeds represented income or capital. The terms of issue of the B Shares allowed the Company to arrange for all outstanding B Shares to be purchased at any time after July 2009 and it was always intended that this would be done at an appropriate time. The Board has now decided that it would be appropriate to exercise this power.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUOOARSWAVAUR
Date   Source Headline
1st May 20248:58 amRNSDirector/PDMR Shareholding
30th Apr 20244:34 pmRNSTotal Voting Rights
2nd Apr 20248:01 amRNSPortfolio Update
28th Mar 20241:02 pmRNSTotal Voting Rights
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 20241:53 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 202410:11 amRNSDirector/PDMR Shareholding
29th Feb 20244:21 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNS3i Group plc - Q3 performance update
31st Jan 20244:17 pmRNSTotal Voting Rights
31st Jan 20244:14 pmRNSDirector/PDMR Shareholding
4th Jan 20243:36 pmRNSTotal Voting Rights
4th Jan 20243:35 pmRNSDirector/PDMR Shareholding
3rd Jan 202412:00 pmRNSPortfolio Update
8th Dec 20231:11 pmRNSBlock listing Interim Review
30th Nov 20234:55 pmRNSTotal Voting Rights
30th Nov 20234:51 pmRNSDirector/PDMR Shareholding
23rd Nov 202311:11 amRNSDirector Declaration
20th Nov 20239:13 amRNSDirector Declaration
9th Nov 20232:29 pmRNSDirector/PDMR Shareholding
9th Nov 202311:49 amRNSDoc re. Half Yearly Report 2023
9th Nov 20237:00 amRNSHalf-year Report
31st Oct 20233:29 pmRNSTotal Voting Rights
31st Oct 20233:27 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:58 pmRNSDirector/PDMR Shareholding
2nd Oct 202310:36 amRNSPortfolio Update
28th Sep 20231:35 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSUpdate on portfolio and Capital Markets Seminar
12th Sep 202310:43 amRNSDirector/PDMR Shareholding
4th Sep 202310:41 amRNSDirector/PDMR Shareholding
31st Aug 20233:56 pmRNSTotal Voting Rights
31st Aug 20233:52 pmRNSDirector/PDMR Shareholding
1st Aug 202311:40 amRNSDirector/PDMR Shareholding
31st Jul 20234:31 pmRNSTotal Voting Rights
31st Jul 20234:27 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFY2024 Q1 performance update
3rd Jul 202310:25 amRNSPortfolio Update
30th Jun 20233:43 pmRNSTotal Voting Rights
30th Jun 20233:37 pmRNSDirector/PDMR Shareholding
30th Jun 202311:01 amRNSDirector/PDMR Shareholding
29th Jun 20235:00 pmRNSDirectorate Change
29th Jun 20233:46 pmRNSDirector/PDMR Shareholding
29th Jun 20233:31 pmRNSDoc re. AGM Resolutions
29th Jun 20233:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM and portfolio update
28th Jun 20232:34 pmRNSDirector/PDMR Shareholding
12th Jun 20232:33 pmRNSPublication of a Prospectus
9th Jun 20239:44 amRNSBlock listing Interim Review
8th Jun 20232:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.